Optimizing Market Access – A Guide to Effective Pricing, Reimbursement and Messaging Strategies

In today's competitive market, pricing and reimbursement strategies are key to maximizing brand success and ROI. Because every country's healthcare system is different-and every product situation is unique-every brand requires a specific access plan, tailored to each market. And you must support each plan with effective messaging that ensures strong product acceptance and uptake. Experts from TNS Healthcare spoke on this issue in a recent webinar and during an exclusive interview with Pharma Marketing News.

Free Drug Samples – The Sales Rep’s Last Great Hope?

Should free drug samples be banned? The new PhRMA Code on Interactions with Healthcare Professionals bans free pens and out-of-office lunches, but it doesn't ban samples. Many sales consider free drug samples an important marketing tactic that they can employ to gain access to physicians. In 2005, the pharmaceutical industry distributed more than $18 billion worth of drug samples. But critics are concerned that drug samples increase costs, raise questions about the appropriateness of treatment choices, and create real or perceived conflicts of interest in the medical profession.

Free Drug Samples – The Sales Rep’s Last Great Hope?

Should free drug samples be banned? The new PhRMA Code on Interactions with Healthcare Professionals bans free pens and out-of-office lunches, but it doesn't ban samples. Many sales consider free drug samples an important marketing tactic that they can employ to gain access to physicians. In 2005, the pharmaceutical industry distributed more than $18 billion worth of drug samples. But critics are concerned that drug samples increase costs, raise questions about the appropriateness of treatment choices, and create real or perceived conflicts of interest in the medical profession.

Understanding the Strategic Value of MSLs

This article examines how tomorrow's MSL might be employed by Pharma and discusses the strategic movement of MSLs into the competitive intelligence space, teaching roles, strategic input to and evaluation of portfolio development, and investor relations.

Pharma Marketing News Vol. 7, #4

Vol. 7, No. 4: April 2008 - EXECUTIVE SUMMARY Welcome to this issue of Pharma Marketing News. Subscribe Now to get the current and future issues FREE!...

Pharma Marketing News Vol. 7, #6

Welcome to the June/July, 2008 issue of Pharma Marketing News.

I’m All a Twitter Over Twitter!

I recently discovered Twitter-a free social networking and micro-blogging service-and admit that 'I'm All a Twitter Over Twitter.'

FDA’s Good Reprint Practices Guidance

Medical journals may soon become the pharmaceutical industry's newest physician marketing partner. This article summarizes some of the pros and cons of FDA's Good Reprint Practices Guidance and presents preliminary results of a reader survey on the topic.

Pharma Marketing News Vol. 7, #1

Vol. 7, No. 1: January 2008 - EXECUTIVE SUMMARY Welcome to this issue of Pharma Marketing News. Subscribe Now to get the current and future issues FREE!...

Pharma Marketing News Vol. 7, #2

Welcome to the February, 2008 issue of Pharma Marketing News.
- Advertisement -